Ironsides Asset Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Ironsides Asset Advisors's NVO Position: Q2 2026 in Review
Ironsides Asset Advisors sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 6,623 shares — an estimated $243K sold.
Ironsides Asset Advisors first reported a position in NVO in Q3 2019 and held it in 24 quarters. The position peaked at $805K in Q3 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Ironsides Asset Advisors reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
- Ironsides Asset Advisors sold 6,623 Novo Nordisk shares in Q2 2026, an estimated $243K.
- Ironsides Asset Advisors first reported a position in Novo Nordisk in Q3 2019 and held it in 24 quarters.
- Ironsides Asset Advisors's Novo Nordisk position peaked at $805K in Q3 2024.
- 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Ironsides Asset Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.